1092394-16-5

Basic information

• Product Name: 2-Amino[1,2,4]triazolo[1,5-a]pyridin-6-olhydrobromide
• Synonyms: 2-Amino[1,2,4]triazolo[1,5-a]pyridin-6-olhydrobromide;2-AMINO-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-OL HBR
• CAS NO: 1092394-16-5
• Molecular Formula: C6H7BrN4O
• Molecular Weight: 231.04998
• Mol File: 1092394-16-5.mol

Chemical Properties

• Appearance: /
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: 2-Amino[1,2,4]triazolo[1,5-a]pyridin-6-olhydrobromide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Amino[1,2,4]triazolo[1,5-a]pyridin-6-olhydrobromide(1092394-16-5)
• EPA Substance Registry System: 2-Amino[1,2,4]triazolo[1,5-a]pyridin-6-olhydrobromide(1092394-16-5)

Safety Data

• Hazardous Substances Data: 1092394-16-5(Hazardous Substances Data)

Usage

Uses

Used in Medicinal Chemistry:
2-Amino[1,2,4]triazolo[1,5-a]pyridin-6-olhydrobromide is used as a chemical entity for its potential to interact with biological targets due to its unique ring structure and functional groups. Its application in medicinal chemistry is driven by the need to explore new compounds with therapeutic properties.
Used in Drug Discovery:
In the pharmaceutical industry, 2-Amino[1,2,4]triazolo[1,5-a]pyridin-6-olhydrobromide is used as a lead compound for drug discovery. Its complex structure and functional groups make it a promising candidate for the development of new drugs, particularly those targeting specific biological pathways or receptors.
Further research is necessary to fully understand the properties and potential uses of 2-Amino[1,2,4]triazolo[1,5-a]pyridin-6-olhydrobromide, including its bioavailability, pharmacokinetics, and pharmacodynamics, as well as its safety and efficacy in various therapeutic applications.

Upstream product

• 10167-97-2 2-amino-5-methoxypyridine 
• 1092394-15-4 6-methoxy-[1,2,4]triazolo[1,5-a]pyridin-2-amine 

Downstream Products

• 1092394-69-8 N-[6-(3-fluoro-5-nitrophenoxy)[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide 
• 1092391-65-5 N-[3-({2-[(cyclopropylcarbonyl)amino][1,2,4]triazolo[1,5-a]pyridin-6-yl}oxy)-5-fluorophenyl]-1,3-dimethyl-1H-pyrazole-5-carboxamide 
• 1195781-63-5 N-[6-(4-amino-2-fluorophenoxy)[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide 
• 1195781-62-4 N-[6-(2-fluoro-4-nitrophenoxy)[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide 

Relevant articles and documents

FUSED HETEROCYCLIC DERIVATIVES AND USE THEREOF

The present invention provides a fused heterocyclic derivative having a strong kinase inhibitory activity and use thereof. The present invention relates to a compound represented by the formula wherein each symbol is as defined in the present specificatio

HETEROBICYCLIC COMPOUNDS AS KINASE INHIBITORS

A compound represented by the formula (I): wherein Z1,Z2,Z3 and Z4 are the following combination, (Z1,Z2,Z3,Z4)=(CR4,N,CR5,C), (N,N,CR5,C), (N,C,CR5,N), (S,C,CR5,C) or (S,C,N,C); R1 and R2 are the same or different and each is (1) a hydrogen atom, (2) a halogen atom, (3) a group bonded via a carbon atom, (4) a group bonded via a nitrogen atom, (5) a group bonded via an oxygen atom or (6) a group bonded via a sulfur atom; R 3 is an amino optionally having substituent(s); R4 and R 5 are the same or different and each is (1) a hydrogen atom, (2) a halogen atom, (3) a group bonded via a carbon atom, (4) a group bonded via a nitrogen atom, (5) a group bonded via an oxygen atom or (6) a group bonded via a sulfur atom; R3 and R4 optionally form a ring optionally having substituent(s); and a group represented by the formula (A) is a cyclic group optionally having substituent(s), or a salt thereof